Andreas Laupacis - Publications

Affiliations: 
Health Policy, Management and Evaluation University of Toronto, Toronto, ON, Canada 
Area:
Pharmacy, Public Health, Health Care Management

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Verma AA, Guo Y, Jung HY, Laupacis A, Mamdani M, Detsky AS, Weinerman A, Tang T, Rawal S, Lapointe-Shaw L, Kwan JL, Razak F. Physician-level variation in clinical outcomes and resource use in inpatient general internal medicine: an observational study. Bmj Quality & Safety. PMID 32220936 DOI: 10.1136/Bmjqs-2019-010425  0.304
2015 Kirkham KR, Wijeysundera DN, Pendrith C, Ng R, Tu JV, Laupacis A, Schull MJ, Levinson W, Bhatia RS. Preoperative testing before low-risk surgical procedures. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. PMID 26032314 DOI: 10.1503/Cmaj.150174  0.3
2014 Dhalla IA, O'Brien T, Morra D, Thorpe KE, Wong BM, Mehta R, Frost DW, Abrams H, Ko F, Van Rooyen P, Bell CM, Gruneir A, Lewis GH, Daub S, Anderson GM, ... ... Laupacis A, et al. Effect of a postdischarge virtual ward on readmission or death for high-risk patients: a randomized clinical trial. Jama. 312: 1305-12. PMID 25268437 DOI: 10.1001/Jama.2014.11492  0.336
2014 Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, et al. Atrial fibrillation in patients with cryptogenic stroke. The New England Journal of Medicine. 370: 2467-77. PMID 24963566 DOI: 10.1056/Nejmoa1311376  0.438
2012 Dhalla IA, O'Brien T, Ko F, Laupacis A. Toward safer transitions: how can we reduce post-discharge adverse events? Healthcare Quarterly (Toronto, Ont.). 15: 63-7. PMID 22874449 DOI: 10.12927/Hcq.2012.22839  0.327
2011 Quinn RR, Hux JE, Oliver MJ, Austin PC, Tonelli M, Laupacis A. Selection bias explains apparent differential mortality between dialysis modalities. Journal of the American Society of Nephrology : Jasn. 22: 1534-42. PMID 21784891 DOI: 10.1681/Asn.2010121232  0.326
2011 Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women Jama - Journal of the American Medical Association. 305: 783-789. PMID 21343577 DOI: 10.1001/Jama.2011.190  0.684
2011 Quinn RR, Laupacis A, Hux JE, Oliver MJ, Austin PC. Predicting the risk of 1-year mortality in incident dialysis patients: accounting for case-mix severity in studies using administrative data. Medical Care. 49: 257-66. PMID 21301370 DOI: 10.1097/Mlr.0B013E318202Aa0B  0.301
2010 Quinn RR, Laupacis A, Austin PC, Hux JE, Garg AX, Hemmelgarn BR, Oliver MJ. Using administrative datasets to study outcomes in dialysis patients: a validation study. Medical Care. 48: 745-50. PMID 20613656 DOI: 10.1097/Mlr.0B013E3181E419Fd  0.32
2010 Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: A population-based study Archives of Internal Medicine. 170: 617-621. PMID 20386005 DOI: 10.1001/Archinternmed.2010.37  0.334
2009 Evans WK, Laupacis A, Gulenchyn KY, Levin L, Levine M. Evidence-based approach to the introduction of positron emission tomography in ontario, Canada. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5607-13. PMID 19858395 DOI: 10.1200/Jco.2009.22.1614  0.479
2009 Park-Wyllie LY, Mamdani MM, Li P, Gill SS, Laupacis A, Juurlink DN. Cholinesterase inhibitors and hospitalization for bradycardia: A population-based study Plos Medicine. 6. PMID 19787032 DOI: 10.1371/Journal.Pmed.1000157  0.711
2009 Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 180: 183-93. PMID 19050037 DOI: 10.1503/Cmaj.081109  0.354
2007 Schull MJ, Stukel TA, Vermeulen MJ, Zwarenstein M, Alter DA, Manuel DG, Guttmann A, Laupacis A, Schwartz B. Effect of widespread restrictions on the use of hospital services during an outbreak of severe acute respiratory syndrome Cmaj. 176: 1827-1832. PMID 17576979 DOI: 10.1503/Cmaj.061174  0.319
2005 Shah BR, Hux JE, Laupacis A, Zinman B, Van Walraven C. Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary care physicians? Diabetes Care. 28: 600-606. PMID 15735195 DOI: 10.2337/Diacare.28.3.600  0.305
2005 Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors Archives of Internal Medicine. 165: 189-192. PMID 15668365 DOI: 10.1001/Archinte.165.2.189  0.342
2005 Juurlink DN, Mamdani MM, Kopp A, Herrmann N, Laupacis A. A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin British Journal of Clinical Pharmacology. 59: 102-107. PMID 15606447 DOI: 10.1111/J.1365-2125.2005.02230.X  0.324
2004 Alter DA, Manuel DG, Gunraj N, Anderson G, Naylor CD, Laupacis A. Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies The American Journal of Medicine. 116: 540-545. PMID 15063816 DOI: 10.1016/J.Amjmed.2003.10.039  0.329
2004 Carless PA, Henry DA, Moxey AJ, O'Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D. Desmopressin for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews. CD001884. PMID 14973974 DOI: 10.1002/14651858.CD001884.pub2  0.341
2003 Man-Son-Hing M, Laupacis A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded Jama Internal Medicine. 163: 1580-1586. PMID 12860581 DOI: 10.1001/Archinte.163.13.1580  0.338
2003 Walraven Cv, Hart RG, Wells GA, Petersen P, Koudstaal PJ, Gullov AL, Hellemons BSP, Koefed BG, Laupacis A. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Jama Internal Medicine. 163: 936-943. PMID 12719203 DOI: 10.1001/Archinte.163.8.936  0.335
2003 Mamdani M, Rochon P, Juurlink DN, Anderson GM, Kopp A, Naglie G, Austin PC, Laupacis A. Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly Archives of Internal Medicine. 163: 481-486. PMID 12588209 DOI: 10.1001/Archinte.163.4.481  0.313
2002 Walraven Cv, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. Jama. 288: 2441-2448. PMID 12435257 DOI: 10.1001/Jama.288.19.2441  0.33
2002 Man-Son-Hing M, Laupacis A. Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation Jama Internal Medicine. 162: 541-550. PMID 11871922 DOI: 10.1001/Archinte.162.5.541  0.319
2001 Henry DA, Moxey AJ, Carless PA, O'Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D. Desmopressin for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews. CD001884. PMID 11406016 DOI: 10.1002/14651858.CD001884  0.341
2001 Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Jama Internal Medicine. 161: 1405-1410. PMID 11386889 DOI: 10.1001/Archinte.161.11.1405  0.321
2001 Hutchinson AB, Fergusson D, Graham ID, Laupacis A, Herrin J, Hillyer CD. Utilization of technologies to reduce allogeneic blood transfusion in the United States Transfusion Medicine. 11: 79-85. PMID 11299024 DOI: 10.1046/J.1365-3148.2001.00290.X  0.46
2001 Henry DA, Moxey AJ, Carless PA, O'Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews. CD001886. PMID 11279735 DOI: 10.1002/14651858.CD001886  0.337
2001 Fergusson D, Laupacis A, Salmi LR, McAlister FA, Huet C. What should be included in meta-analyses? An exploration of methodological issues using the ISPOT meta-analyses. International Journal of Technology Assessment in Health Care. 16: 1109-19. PMID 11155831 DOI: 10.1017/S0266462300103150  0.343
2000 Coyle D, Lee KM, Fergusson DA, Laupacis A. Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery. Pharmacoeconomics. 18: 161-171. PMID 11067650 DOI: 10.2165/00019053-200018020-00006  0.431
2000 Man-Son-Hing M, Laupacis A, O'Connor AM, Coyle D, Berquist R, McAlister F. Patient preference-based treatment thresholds and recommendations: A comparison of decision-analytic modeling with the probability-tradeoff technique Medical Decision Making. 20: 394-403. PMID 11059472 DOI: 10.1177/0272989X0002000403  0.305
2000 Graham ID, Fergusson D, McAuley L, Laupacis A. The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals. International Journal of Technology Assessment in Health Care. 16: 228-241. PMID 10815367 DOI: 10.1017/S0266462300161197  0.457
1999 Huët C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesthesia and Analgesia. 89: 861-9. PMID 10512256 DOI: 10.1097/00000539-199910000-00009  0.4
1999 Clark HD, Wells GA, Huët C, McAlister FA, Salmi LR, Fergusson D, Laupacis A. Assessing the quality of randomized trials: Reliability of the Jadad scale Controlled Clinical Trials. 20: 448-452. PMID 10503804 DOI: 10.1016/S0197-2456(99)00026-4  0.341
1999 Walraven Cv, Mahon JL, Moher D, Bohm C, Laupacis A. Surveying physicians to determine the minimal important difference: implications for sample-size calculation. Journal of Clinical Epidemiology. 52: 717-723. PMID 10465315 DOI: 10.1016/S0895-4356(99)00050-5  0.308
1999 Man-Son-Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, Hartf RG. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: A randomized controlled trial Journal of the American Medical Association. 282: 737-743. PMID 10463708 DOI: 10.1001/Jama.282.8.737  0.339
1999 Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Jama Internal Medicine. 159: 677-685. PMID 10218746 DOI: 10.1001/Archinte.159.7.677  0.327
1999 Fergusson D, vanWalraven C, Coyle D, Laupacis A. Economic evaluations of technologies to minimize perioperative transfusion: A systematic review of published studies Transfusion Medicine Reviews. 13: 106-117. PMID 10218234 DOI: 10.1016/S0887-7963(99)80005-4  0.437
1999 Nichol G, Stiell IG, Hebert P, Wells GA, Vandemheen K, Laupacis A. What Is the Quality of Life for Survivors of Cardiac Arrest? A Prospective Study Academic Emergency Medicine. 6: 95-102. PMID 10051899 DOI: 10.1111/J.1553-2712.1999.Tb01044.X  0.302
1999 Huët C, Salmi LR, Fergusson D, Gemert AWMMK, Rubens F, Laupacis A. A Meta-analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery Anesthesia & Analgesia. 89: 861-869. DOI: 10.1213/00000539-199910000-00009  0.476
1999 Fergusson D, Blair A, Henry D, Hisashige A, Huet C, Gemert AK, Katz E, McClelland B, Sigmund H, Laupacis A. Technologies to minimize blood transfusion in cardiac and orthopedic surgery : Results of a practice variation survey in nine countries International Journal of Technology Assessment in Health Care. 15: 717-728. DOI: 10.1017/S0266462399154114  0.457
1999 Nichol G, Stiel IG, Wells GA, Juergensen LS, Laupacis A. An economic analysis of the ottawa knee rule Annals of Emergency Medicine. 34: 438-447. DOI: 10.1016/S0196-0644(99)80044-4  0.302
1998 Rubens FD, Fergusson D, Wells PS, Huang M, McGowan JL, Laupacis A. Platelet-rich plasmapheresis in cardiac surgery: A meta-analysis of the effect on transfusion requirements Journal of Thoracic and Cardiovascular Surgery. 116: 641-647. PMID 9766594 DOI: 10.1016/S0022-5223(98)70172-2  0.473
1998 Faught C, Wells P, Fergusson D, Laupacis A. Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature. Transfusion Medicine Reviews. 12: 206-225. PMID 9673005 DOI: 10.1016/S0887-7963(98)80061-8  0.451
1998 Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: Results of a meta- analysis Archives of Internal Medicine. 158: 610-616. PMID 9521225 DOI: 10.1001/Archinte.158.6.610  0.451
1998 Bryson GL, Laupacis A, Wells GA. Does Acute Normovolemic Hemodilution Reduce Perioperative Allogeneic Transfusion? A Meta-Analysis Anesthesia & Analgesia. 86: 9-15. DOI: 10.1213/00000539-199801000-00003  0.318
1997 Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery : Meta-analyses using perioperative blood transfusion as the outcome Anesthesia & Analgesia. 85: 1258-1267. PMID 9390590 DOI: 10.1097/00000539-199712000-00014  0.457
1997 McAlister FA, Laupacis A, Teo KK, Hamilton PG, Montague TJ. A survey of clinician attitudes and management practices in hypertension. Journal of Human Hypertension. 11: 413-9. PMID 9283056 DOI: 10.1038/Sj.Jhh.1000457  0.31
1996 Blackshear JL, Baker VS, Rubino F, Safford R, Lane G, Flipse T, Malouf J, Thompson R, Webel R, Flaker GC, Young L, Hess D, Friedman G, Burger R, McAnulty JH, ... ... Laupacis A, et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial Lancet. 348: 633-638. PMID 8782752 DOI: 10.1016/S0140-6736(96)03487-3  0.306
1996 Nichol G, Detsky AS, Stiell IG, O'Rourke K, Wells G, Laupacis A. Effectiveness of Emergency Medical Services for Victims of Out-of-Hospital Cardiac Arrest: A Metaanalysis Annals of Emergency Medicine. 27: 700-710. PMID 8644956 DOI: 10.1016/S0196-0644(96)70187-7  0.317
1996 Mahon J, Laupacis A, Donner A, Wood T. Randomised study of n of 1 trials versus standard practice. Bmj. 312: 1069-1074. PMID 8616414 DOI: 10.1136/Bmj.312.7038.1069  0.314
1996 Man-Son-Hing M, Laupacis A, O'Connor A, Wells G, Lemelin J, Wood W, Dermer M. Warfarin for atrial fibrillation. The patient's perspective. Jama Internal Medicine. 156: 1841-1848. DOI: 10.1001/Archinte.1996.00440150095011  0.343
1995 Stiell I, Wells G, Laupacis A, Brison R, Verbeek R, Vandemheen K, Naylor CD. Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. Bmj. 311: 594-597. PMID 7663253 DOI: 10.1136/Bmj.311.7005.594  0.302
1994 Guyatt GH, Sackett DL, Cook DJ, Guyatt G, Bass E, Brill Edwards P, Browman G, Cook D, Farkouh M, Gerstein H, Haynes B, Hayward R, Holbrook A, Jaeschke R, Juniper E, ... Laupacis A, et al. Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention B. What Were the Results and Will They Help Me in Caring for My Patients? Jama: the Journal of the American Medical Association. 271: 59-63. PMID 8258890 DOI: 10.1001/Jama.1994.03510250075039  0.349
1993 Turpie A, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement The New England Journal of Medicine. 329: 524-529. PMID 8336751 DOI: 10.1056/Nejm199308193290802  0.335
1992 Sheingold S, Churchill D, Muirhead N, Laupacis A, Labelle R, Goeree R. The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada Social Science and Medicine. 34: 983-991. PMID 1631611 DOI: 10.1016/0277-9536(92)90129-E  0.342
1991 Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian atrial fibrillation anticoaguiation (CAFA) study Journal of the American College of Cardiology. 18: 349-355. PMID 1856403 DOI: 10.1016/0735-1097(91)90585-W  0.342
1991 Laupacis A, Connolly SJ, Gent M, Roberts RS, Cairns J, Joyner C. How should results from completed studies influence ongoing clinical trials? The CAFA Study experience. Annals of Internal Medicine. 115: 818-22. PMID 1834003 DOI: 10.7326/0003-4819-115-10-818  0.35
1989 Laupacis A, Rorabeck CH, Bourne RB, Feeny D, Tugwell P, Sim DA. Randomized trials in orthopaedics: why, how, and when? Journal of Bone and Joint Surgery, American Volume. 71: 535-543. DOI: 10.2106/00004623-198971040-00009  0.305
Show low-probability matches.